1. In Vivo

C-Suite Snippets: Medtech Leaders

Digital Trends And New EU Regulations

 
• By Lucie Ellis-Taitt

In case you missed it: catch up with snippets from interviews published by In Vivo this week. 

CEOs_panel_MTF_2019
Medtech leaders discuss key issues at the MedTech Forum Conference In Paris • Source: Ashley Yeo

Peters Surgical’s Thierry Herbreteau expresses his real concerns about the effects of the incoming European Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) at the MedTech Forum 2019 in Paris.

ResMed’s Mick Farrell extols the need to move to digital solutions, but he prefers the term “machine learning” to the overused “AI.”

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Business Strategy

More from In Vivo

How Vir Bio CEO Marianne De Backer Is Rebuilding Commercial Momentum

 
• By David Wild

From billion-dollar COVID antibody to a strategic reset, Marianne De Backer is navigating Vir's comeback through pipeline focus and disciplined leadership.

Execs On The Move: April 2025

 
• By In Vivo Team

An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

AI In Drug Discovery: The Patent Implications

 
• By David Wild

A Q&A with DeAnn Smith, partner and co-chair of the Patent Trial and Appeal Board Proceedings Practice Group at law firm Foley Hoag.